Aviado · Research
Longevity Daily
Sunday, June 28, 2026
Listen
Today's Brief
Today's standout story is a landmark JAMA finding: intensive lifestyle intervention — not metformin — meaningfully reduces multimorbidity risk in people with prediabetes, a result that reframes metabolic prevention for anyone optimizing their health. New research also reveals that vitamin B12 deficiency can convincingly mimic normal aging, raising urgent questions about misdiagnosis in older adults and metformin users. Cell type-specific aging clocks are emerging as powerful early-warning systems for Alzheimer's and other diseases. Our Aviado analysis gives you a precise decision framework for krill oil — including exactly when to stop taking it.
10 stories4 peer-reviewed1 trials1 Aviado original
Cognitive Health & Neuroprotection
Cell Type-Specific Aging Clocks Can Predict Alzheimer's and Cancer Onset Years Ahead
A new study used aging trajectories across distinct cell types — rather than a single composite biological age score — to predict the onset of Alzheimer's disease and lung cancer with greater precision than existing methods. This matters because a whole-body biological age clock misses the early, cell-specific changes that precede disease by years or decades. The research points toward a future where disease-specific aging biomarkers replace one-size-fits-all clocks for targeted, personalized intervention.
Read more →Supplements & Compounds
AG1 vs. a Rival Formula Tested Head-to-Head in Worms: One Preserved Mobility Significantly Better
A new study in Biogerontology pitted AG1 (70+ ingredients, 5 probiotic strains) against V14 (40+ ingredients including NMN, resveratrol, taurine, and pterostilbene) in C. elegans worms, finding that V14 better preserved mobility with age and modulated metabolism- and stress-response gene expression associated with longevity. Critical caveat: worm studies don't reliably translate to humans, and the research may be industry-adjacent. Still, this is one of the few head-to-head comparisons of commercial longevity formulas in a validated aging model — and it raises pointed questions about whether ingredient count drives outcomes.
Read more →Krill Oil Reliably Cuts Triglycerides — But Leaves Cholesterol Untouched: What That Split Tells You
Across multiple high-quality trials, krill oil consistently lowers blood triglycerides but barely moves LDL or HDL cholesterol — a finding that's both reassuring and limiting, depending on your goals. The practical upshot: take 2–4 grams daily (split doses with meals) for 12 weeks, then check your triglycerides; if they haven't dropped by at least 10 mg/dL, the evidence says you're a non-responder regardless of dose or duration. This makes krill oil one of the few supplements where your personal response is definitively measurable with a standard blood panel.
Read the full Aviado analysis →Low B12 Mimics Normal Aging So Closely That Millions May Be Misdiagnosed
New research finds that B12 deficiency produces cognitive fog, fatigue, and balance problems so similar to normal aging that widespread misdiagnosis is likely occurring — particularly in adults over 60, where stomach acid production declines and B12 absorption drops. The risk compounds for anyone taking metformin or proton-pump inhibitors, both of which impair B12 absorption over time, and for those on plant-based diets. Getting your B12 tested and targeting the upper third of the reference range may be one of the simplest, highest-yield interventions for older adults.
Read more →Research & Papers
Landmark JAMA Trial: Lifestyle Change Prevents Multiple Chronic Diseases in Prediabetes — Metformin Does Not
A landmark long-term study published in JAMA found that intensive lifestyle intervention — targeting 7% body weight loss and 150 minutes of weekly physical activity — significantly reduced the risk of adults with prediabetes developing multiple chronic conditions simultaneously. Metformin, the widely used diabetes drug and longevity-adjacent compound, showed no meaningful advantage over placebo for this multimorbidity endpoint. This finding cuts through a significant amount of hype: for metabolic disease prevention, no pharmacological shortcut yet matches genuine lifestyle change. If you have prediabetes or elevated fasting glucose, this is the most actionable finding of the week.
Read more →Rapamycin Extended Mouse Lifespan by 38% — Here's What the Evidence Actually Says
Discovered accidentally in a 1964 Easter Island soil sample, rapamycin inhibits mTOR — the same longevity pathway suppressed by caloric restriction — and has produced the largest lifespan extension ever documented in a mammal (up to 38% in mice). This deep-dive feature explains why rapamycin has become the most closely watched compound in geroscience, and how intermittent dosing strategies may sidestep its immunosuppressive effects. Multiple human trials are underway, making this a good moment to understand the underlying science before the results land.
Read more →Diabetes and Muscle Loss Form a Deadly Bidirectional Loop — Linked to 59% of 5-Year Mortality
A large prospective cohort study of aging Chinese adults (2008–2018 follow-up) found that developing diabetes raises your risk of subsequent sarcopenia by 82%, while developing sarcopenia raises your risk of subsequent diabetes by 65% — a compounding, bidirectional cycle. Most striking: 58.9% of all 5-year mortality was attributable to entering any chronic disease state, underscoring how much is at stake in the early prevention window. For longevity-focused readers, this is a powerful argument for prioritizing both resistance training and metabolic health simultaneously — not as separate goals, but as a unified strategy.
Read more →Lifestyle & Nutrition
3-Minute 'Exercise Snacks' Deliver Real Cardiovascular and Metabolic Gains, Research Shows
Brief exercise snacks of 3 minutes or less — stair climbing, bodyweight intervals, brisk walks — appear to produce meaningful improvements in VO2 max, insulin sensitivity, and cardiovascular markers when repeated multiple times throughout the day. The concept lowers the barrier to movement and may be especially valuable for breaking up sedentary work hours, which independently raise disease risk even in people who exercise regularly. Note: underlying study designs vary in sample size and duration — this is promising evidence, not a full substitute for structured training.
Read more →The Gut-Ovary Axis: Why Ovarian Health Is a Longevity Issue, Not Just a Fertility Question
Nutrition expert Ayla Barmmer argues that ovarian health drives far more than reproductive function — it's directly tied to metabolic health, immune aging, and longevity through what's emerging as the gut-ovary axis. As ovarian function declines with age, systemic effects ripple through inflammation, bone density, cardiovascular risk, and cognitive health — all key longevity levers. For women in their 30s–50s, the implication is clear: menopause optimization is a longevity intervention, not just symptom management.
Read more →Industry & Policy
SIRT6 Gene Therapy Shows Healthspan Benefits in Aged Dogs — Human Implications in Sight
Genflow Biosciences is presenting results from its Age Dogs trial at the Animal Longevity Summit, showing that SIRT6 gene therapy — based on a genetic variant found in centenarians — improves healthspan markers in senior dogs. Dogs are increasingly valued as longevity research models because they share our environment and develop similar age-related diseases, making this more translatable than typical rodent data. If the results hold up to scrutiny, SIRT6 becomes one of the most compelling gene therapy targets for human aging — and Genflow a company worth tracking.
Read more →